Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 26, 2016Pharmacy PracticeOpen Access

Immunosuppressive serum levels in allogeneic hematopoietic stem cell transplantation: pharmaceutical care contribution

View Full Paper
Ask AI
Bookmark
Share

Authors

PCPaulo Maximiliano CorrêaUniversidade Federal de PelotasJZJoice ZuckermannHospital de Clínicas de Porto AlegreGFGustavo Brandão Fischer

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Corrêa et al. (2016) studied this question.

synapsesocial.com/papers/6aa83ad70a32928ecb3944dbhttps://doi.org/10.18549/pharmpract.2016.02.683
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1D iagnosis and management of acute graft‐versus‐host disease2012 · 314 citations
  2. 2CYP3A5*3 and POR*28 Genetic Variants Influence the Required Dose of Tacrolimus in Heart Transplant Recipients2014 · 36 citations
  3. 3CYP3A5 Polymorphism Effect on Cyclosporine Pharmacokinetics in Living Donor Renal Transplant Recipients: Analysis by Population Pharmacokinetics2012 · 16 citations
  4. 4Impact of clinical pharmacy services on renal transplant patients’ compliance with immunosuppressive medications2001 · 178 citations
  5. 5Serum Cyclosporine Concentration and Risk of Acute Graft-versus-Host Disease after Allogeneic Marrow Transplantation1988 · 126 citations